12月19日(路透社)- Bactiguard Holding AB宣布与齐默巴奥米特更新创伤许可协议,重新获得创伤领域的剩余全球权利。新协议不再包括年度最低特许权使用费,将从齐默巴奥米特收取季度固定费用。从年度角度来看,固定费用不少于之前全球创伤协议中最低特许权使用费的一半。更新后的协议对2025年没有负面影响。
12月19日(路透社)- Bactiguard Holding AB宣布与齐默巴奥米特更新创伤许可协议,重新获得创伤领域的剩余全球权利。新协议不再包括年度最低特许权使用费,将从齐默巴奥米特收取季度固定费用。从年度角度来看,固定费用不少于之前全球创伤协议中最低特许权使用费的一半。更新后的协议对2025年没有负面影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.